Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RTW Investments
Biotech
Candel glows with $100M RTW deal to fund cancer drug launch
As Candel gears up for a planned U.S. approval push for its prostate cancer drug, RTW has stepped in with $100 million to bankroll the launch.
James Waldron
Feb 20, 2026 4:04am
Corxel secures $287M series D to fund oral GLP-1 studies
Jan 22, 2026 10:22am
RTW-built biotech's $520M deal for InnoCare, Keymed bispecific
Jan 21, 2025 4:32am
Kailera launches with $400M series A, 4 Chinese obesity drugs
Oct 1, 2024 8:30am
Flagship CEO says firm has work to do before inking China pacts
Jan 8, 2024 9:05pm
Few biotechs dare to test 'eerie' Wall Street IPO market
May 8, 2023 6:00am
